☆ 4.5 Article

Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood

CARDIOVASCULAR DRUGS AND THERAPY (2015)

Get Full Text
Add to Collection

Journal

CARDIOVASCULAR DRUGS AND THERAPY
Volume 29, Issue 5, Pages 415-418

Publisher

SPRINGER
DOI: 10.1007/s10557-015-6609-2

Keywords

Cangrelor; P2Y12 inhibitor; Cardioprotection; Ischaemia; Reperfusion injury; Anti-platelet

Categories

Cardiac & Cardiovascular Systems Pharmacology & Pharmacy

Funding

  1. NIHR
  2. UCL Cardiometabolic BRC
  3. British Heart Foundation
  4. Medical Research Council
  5. British Heart Foundation [PG/09/106/28142, RG/08/015/26411] Funding Source: researchfish
  6. National Institute for Health Research [NF-SI-0510-10164] Funding Source: researchfish

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.